56 related articles for article (PubMed ID: 3387035)
1. Oestrogen receptor status and risk factors for breast cancer. GIVIO. Interdisciplinary Group for Cancer Care Evaluation (GIVIO), Italy.
Oncology; 1988; 45(4):303-7. PubMed ID: 3387035
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica.
Alfred R; Chin SN; Williams E; Walters C; Barton EN; Shah D
West Indian Med J; 2012 Nov; 61(8):795-801. PubMed ID: 23757900
[TBL] [Abstract][Full Text] [Related]
3. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
[TBL] [Abstract][Full Text] [Related]
4. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
7. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
Potter JD; Cerhan JR; Sellers TA; McGovern PG; Drinkard C; Kushi LR; Folsom AR
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):319-26. PubMed ID: 7655325
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
9. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
Ma H; Bernstein L; Pike MC; Ursin G
Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
[TBL] [Abstract][Full Text] [Related]
10. Relationship between risk factors for breast cancer and hormonal status.
Hislop TG; Coldman AJ; Elwood JM; Skippen DH; Kan L
Int J Epidemiol; 1986 Dec; 15(4):469-76. PubMed ID: 3818154
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor expression in the normal and pre-cancerous breast.
Shoker BS; Jarvis C; Sibson DR; Walker C; Sloane JP
J Pathol; 1999 Jul; 188(3):237-44. PubMed ID: 10419589
[TBL] [Abstract][Full Text] [Related]
12. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
[TBL] [Abstract][Full Text] [Related]
13. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
[TBL] [Abstract][Full Text] [Related]
14. Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy.
Giuliani S; Leonardi E; Aldovini D; Bernardi D; Pellegrini M; Soli F; Ferro A; Dalla Palma P; Decarli N; Barbareschi M
Pathologica; 2012 Jun; 104(3):93-7. PubMed ID: 22931039
[TBL] [Abstract][Full Text] [Related]
15. Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer.
Fohlin H; Pérez-Tenorio G; Fornander T; Skoog L; Nordenskjöld B; Carstensen J; Stål O
Eur J Cancer; 2013 Apr; 49(6):1196-204. PubMed ID: 23305873
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
17. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract][Full Text] [Related]
18. Carotenoids, vitamin A, and estrogen receptor status in breast cancer.
Rock CL; Saxe GA; Ruffin MT; August DA; Schottenfeld D
Nutr Cancer; 1996; 25(3):281-96. PubMed ID: 8771571
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
McTiernan A; Thomas DB; Johnson LK; Roseman D
J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Rojo F; González-Pérez A; Furriol J; Nicolau MJ; Ferrer J; Burgués O; Sabbaghi M; González-Navarrete I; Cristobal I; Serrano L; Zazo S; Madoz J; Servitja S; Tusquets I; Albanell J; Lluch A; Rovira A; Eroles P
Br J Cancer; 2016 Jul; 115(3):322-31. PubMed ID: 27404455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]